玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)91-1.094.60.12-91.11-67.570.38-11.635.562.742.240.376.174.5826.4332.92-0.0912.280.6916.9576.920.11-91.13-65.627.30-70.12-6.532.09-90.34-68.3810.13-3.093.91
23Q3 (19)925.755.751.3584.93107.690.4319.4459.262.68106.1513.565.915.6928.8232.958.469.210.5922.9273.531.2493.75117.5424.4357.3170.9621.6372.2173.464.8056.503.62
23Q2 (18)870.00.00.7328.07-37.610.36-12.2-23.41.30128.07-23.985.1-6.08-32.3630.3811.932.430.482.1314.290.6428.0-37.2515.5341.3115.2112.5636.52-7.782.5941.060.85
23Q1 (17)870.00.00.5754.055.560.4113.8932.260.57-79.125.565.4311.27-29.3927.15-7.435.210.4720.5123.680.556.256.3810.9940.7249.129.2039.1822.58.915.4823.61
22Q4 (16)870.00.00.37-43.08-54.320.3633.33176.922.7315.6846.774.886.55-35.729.32-2.8234.80.3914.7144.440.32-43.86-54.937.81-45.35-31.196.61-46.99-46.95-16.36-43.76-4.61
22Q3 (15)870.00.00.65-44.4462.50.27-42.55-12.92.3638.01124.764.58-39.26-39.6630.1731.5244.70.34-19.05-8.110.57-44.1262.8614.296.01145.1112.47-8.44110.64-20.6136.124.53
22Q2 (14)870.00.01.17116.67485.00.4751.6151.611.71216.67167.197.54-1.952.0322.9414.2418.490.4210.5331.251.02117.02466.6713.4882.9337.6613.6281.36381.27-0.3141.6795.03
22Q1 (13)870.00.00.54-33.3322.730.31138.46-22.50.54-70.9722.737.691.326.8120.08-7.68-12.470.3840.74-19.150.47-33.823.687.37-35.077.287.51-39.7320.930.6634.5940.20
21Q4 (12)870.00.00.81102.5107.690.13-58.06-69.771.8677.1414.117.590.0-4.6521.754.320.930.27-27.03-46.00.71102.86108.8211.3594.6898.7712.46110.47103.591.35101.25-29.03
21Q3 (11)870.00.00.40100.0-32.20.310.00.01.0564.06-14.637.592.71-29.1320.857.724.480.3715.62-11.90.3594.44-32.695.8389.29-5.055.92109.19-1.822.6722.73-11.25
21Q2 (10)870.01.160.20-54.55-42.860.31-22.5-13.890.6445.450.07.392.64-19.4119.36-15.61-0.970.32-31.91-30.430.18-52.63-40.03.08-55.17-34.332.83-54.43-28.72-3.46-20.86-14.74
21Q1 (9)870.00.00.4412.8246.670.40-6.9860.00.44-73.0146.677.2-9.55-7.3422.946.4515.220.47-6.051.610.3811.7646.156.8720.3257.576.211.4753.71-17.62-10.5415.87
20Q4 (8)870.0-2.250.39-33.921.880.4338.714.881.6332.5269.797.96-25.68-22.6421.5528.6620.730.519.056.380.34-34.6217.245.71-7.051.066.121.4953.38-4.4517.3312.41
20Q3 (7)871.16-3.330.5968.5778.790.31-13.89-24.391.2392.1995.2410.7116.792.5916.75-14.32-1.240.42-8.7-12.50.5273.3373.336.1430.9253.56.0351.8952.6617.4142.6215.05
20Q2 (6)86-1.15-4.440.3516.6784.210.3644.0227.270.64113.33113.339.1718.02-2.3419.55-1.8129.130.4648.39170.590.315.3876.474.697.5783.23.97-1.7377.23-3.235.212.49
20Q1 (5)87-2.25-3.330.30-6.25172.730.25-39.021150.00.30-68.75172.737.77-24.49-7.0619.9111.5442.010.31-34.04244.440.26-10.34160.04.3615.34116.924.041.25129.55--0.00
19Q4 (4)89-1.110.00.32-3.030.00.410.00.00.9652.380.010.29-1.440.017.855.250.00.47-2.080.00.29-3.330.03.78-5.50.03.991.010.0--0.00
19Q3 (3)900.00.00.3373.680.00.41272.730.00.63110.00.010.4411.180.016.9612.020.00.48182.350.00.376.470.04.0056.250.03.9576.340.0--0.00
19Q2 (2)900.00.00.1972.730.00.11450.00.00.30172.730.09.3912.320.015.147.990.00.1788.890.00.1770.00.02.5627.360.02.2427.270.0--0.00
19Q1 (1)900.00.00.110.00.00.020.00.00.110.00.08.360.00.014.020.00.00.090.00.00.10.00.02.010.00.01.760.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/32.4514.1837.527.028.827.0N/A-
2024/22.14-11.0424.634.5624.596.64N/A-
2024/12.4115.3724.562.4124.566.56N/A-
2023/122.091.2627.0422.63-8.586.190.56-
2023/112.061.3826.1220.54-11.116.130.57-
2023/102.040.3826.4418.48-13.955.990.58-
2023/92.035.3533.0516.44-17.225.90.3-
2023/81.92-1.326.5514.42-21.45.60.32-
2023/71.9513.2927.2112.49-25.745.430.33-
2023/61.72-2.1-4.8810.54-31.055.110.37-
2023/51.768.12-54.838.82-34.565.160.37主要係子公司業績較去年同期減少,因去年同期正逢國內疫情延燒,子公司搶進快篩試劑通路,帶動去年當期業績大幅成長。
2023/41.63-8.67-11.637.06-26.335.130.37-
2023/31.783.48-31.315.44-29.825.440.31-
2023/21.72-11.09-28.363.66-29.065.30.31-
2023/11.9417.68-29.671.94-29.675.220.32-
2022/121.640.53-33.2324.76-16.844.890.72-
2022/111.641.64-35.1923.11-15.364.770.74-
2022/101.615.62-38.3221.48-13.344.650.76-
2022/91.520.2-33.3419.87-10.44.580.31-
2022/81.52-0.79-43.5418.34-7.764.860.29-
2022/71.53-15.29-41.0116.82-2.157.230.2-
2022/61.81-53.51-23.0115.294.757.540.29-
2022/53.89111.5557.3213.4810.098.330.26主要係子公司於今年國內疫情延燒期間積極搶進快篩試劑市場通路佈局,帶動流通事業的業績大幅成長。
2022/41.84-29.01-28.59.59-1.876.830.32-
2022/32.597.934.57.757.657.750.56-
2022/22.4-12.725.965.159.37.620.57-
2022/12.7511.7212.42.7512.47.740.56-
2021/122.46-2.417.5229.77-16.437.60.72-
2021/112.52-3.25-19.2727.31-18.087.420.74-
2021/102.6114.14-1.1524.78-17.957.590.72-
2021/92.29-15.12-32.7322.17-19.567.580.61-
2021/82.693.65-26.6619.89-17.717.640.6-
2021/72.610.56-27.0217.19-16.117.420.62-
2021/62.35-5.01-24.814.59-13.817.40.65-
2021/52.47-3.86-12.012.24-11.337.530.64-
2021/42.573.75-20.379.77-11.167.320.66-
2021/32.489.43-16.077.2-7.327.20.58-
2021/22.27-7.4214.714.72-1.957.010.6-
2021/12.456.87-13.572.45-13.577.870.53-
2020/122.29-26.74-43.5235.63-7.588.060.68-
2020/113.1318.461.033.33-3.359.170.6-
2020/102.64-22.31-19.1530.21-3.789.710.56-
2020/93.4-7.46-4.7927.57-2.010.630.32-
2020/83.673.145.8524.17-1.5910.360.33-
2020/73.5613.914.5920.5-2.829.50.36-
2020/63.1311.161.4516.93-4.259.170.59-
2020/52.81-13.0-11.7613.81-5.459.00.6-
2020/43.239.367.0211.0-3.698.160.66-
2020/32.9649.575.267.76-7.547.760.73-
2020/21.98-30.25-12.054.81-13.988.870.64-
2020/12.83-30.16-15.272.83-15.279.990.57-
2019/124.0631.0235.9338.5521.4210.420.53-
2019/113.1-5.1818.0334.4919.929.930.56-
2019/103.27-8.513.3631.420.1110.30.54-
2019/93.572.8831.028.1322.4110.440.44-
2019/83.471.9131.6824.5621.259.950.46-
2019/73.410.4930.021.0919.79.670.48-
2019/63.08-3.3117.7417.6917.99.290.4-
2019/53.195.5122.9314.6117.930.0N/A-
2019/43.027.5518.6511.4216.610.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)914.62.710.371.5810.4922.61-8.4230.9725.642.2345.753.2825.192.494.62
2022 (9)870.02.7046.741.4326.5524.69-17.0624.6516.161.536.252.6229.062.3846.91
2021 (8)870.01.8414.291.13-16.329.77-16.4221.2210.351.44-14.792.037.981.6214.08
2020 (7)87-2.251.6169.471.3542.1135.62-7.4319.2319.371.6939.671.8854.11.4265.12
2019 (6)89-1.110.954650.00.95038.4821.7316.1116.231.2101.2200.864200.0
2018 (5)900.00.020.0-0.35031.612.9613.863.51-0.540-0.200.020.0
2017 (4)900.00.02-80.00.040.030.7-8.5213.3914.94-0.320-0.3400.02-85.71
2016 (3)90-3.230.10-79.170.040.033.56-6.6711.650.6-0.480-0.3700.14-68.89
2015 (2)93-1.060.4871.430.04035.96-19.0811.587.22-0.510-0.100.4540.62
2014 (1)940.00.280-0.44044.44-12.1710.800-0.3800.3400.320

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。